Li, W., Wang, Y., Guo, W., & Wen, D. (2025). The status of p53 affects the efficacy of PLK1 inhibitor BI6727 in prostate cancer cells. Frontiers Media S.A.
Chicago Style (17th ed.) CitationLi, Wenjing, Ying Wang, Wenzheng Guo, and Donghua Wen. The Status of P53 Affects the Efficacy of PLK1 Inhibitor BI6727 in Prostate Cancer Cells. Frontiers Media S.A, 2025.
MLA (9th ed.) CitationLi, Wenjing, et al. The Status of P53 Affects the Efficacy of PLK1 Inhibitor BI6727 in Prostate Cancer Cells. Frontiers Media S.A, 2025.
Warning: These citations may not always be 100% accurate.